EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

Pathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy Associated with COVID-19

Toshiyuki Oshitari iD

International Journal of Molecular Sciences · 13.03.2026 · 27 (6) · 2644

DOI: 10.3390/ijms27062644 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.03.2026. Verfasst von Toshiyuki Oshitari. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan. Hauptthemen laut MEDLINE: Optic Neuropathy, Ischemic, COVID-19. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science, Sports, and Culture of the Japanese Government, Eye Research Foundation for the Aged in Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-arteritic ischemic optic neuropathy (NAION) results from vascular insufficiency within the optic nerve head. The precise pathogenesis of NAION remains unclear; however, insufficient blood supply from the short posterior ciliary arteries and the choroidal circulation has been associated with its development. Although major risk factors include diabetes, hypertension, and hyperlipidemia, coronavirus disease 2019 (COVID-19) may also contribute to the development of NAION. This literature review presents our case of NAION associated with COVID-19 infection and summarizes previously reported cases of NAION following COVID-19 infection published in the English-language literature worldwide. Because direct infection of ocular tissues, including ocular vessels, via the angiotensin-converting enzyme 2 receptor is thought to contribute to the development of NAION, cases of NAION associated with COVID-19 vaccination were excluded from this review. Furthermore, we discuss the possible molecular mechanisms underlying the development of NAION after COVID-19 infection and highlight the potential risks of COVID-19 for clinical ophthalmologists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic Neuropathy, IschemicCOVID-19HumansSARS-CoV-2Angiotensin-Converting Enzyme 2Peptidyl-Dipeptidase A

Stichwörter der Autor:innen

COVID-19angiotensin-converting enzyme 2endothelial cellsinfectionmolecular pathologynon-arteritic ischemic neuropathy

Substanzen

Angiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AACE2 protein, human

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba 260-8670, Japan.
  • Department of Ophthalmology, International University of Health and Welfare School of Medicine, 4-3 Kozunomori, Narita 286-8686, Japan.

ORCID-Profile: Toshiyuki Oshitari

Förderung

  • Ministry of Education, Science, Sports, and Culture of the Japanese Government
  • Eye Research Foundation for the Aged in Japan

Zitieren

APA

Oshitari, T. (2026). Pathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy Associated with COVID-19. International Journal of Molecular Sciences, 27(6), 2644. https://doi.org/10.3390/ijms27062644

Vancouver

Oshitari T. Pathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy Associated with COVID-19. International Journal of Molecular Sciences. 2026;27(6):2644. doi:10.3390/ijms27062644

BibTeX
@article{Oshitari2026,
  author = {Oshitari, Toshiyuki},
  title = {Pathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy Associated with COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2644},
  doi = {10.3390/ijms27062644}
}
Kostenlos starten →